Related Experiment Videos
Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes
Abstract:
Characteristic of both obesity and non-insulin-dependent diabetes mellitus, insulin resistance is triggered at the level of the target tissue and can be induced by three general categories of causes: (1) an abnormal beta cell secretory product, (2) circulating insulin antagonists, or (3) a target tissue defect in insulin action. Decreased numbers of insulin receptors and a post-receptor defect in insulin action both play relative roles in insulin resistance. A general trend, however, indicates that as insulin resistance increases, the post-receptor defect becomes more prominent. Impaired glucose uptake and subsequent increased hepatic glucose oxidation in non-insulin-dependent diabetes mellitus are major contributing factors to fasting hyperglycemia.
Insights
Insulin resistance, common in obesity and non-insulin-dependent diabetes mellitus, stems from target tissue issues. Post-receptor defects become more significant as insulin resistance worsens, impacting glucose metabolism.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Molecular Biology
Background:
- Insulin resistance is a key feature of obesity and non-insulin-dependent diabetes mellitus (NIDDM).
- It originates at the target tissue level and is influenced by various factors.
- Understanding its mechanisms is crucial for metabolic disease management.
Purpose of the Study:
- To elucidate the underlying causes and mechanisms of insulin resistance.
- To differentiate the roles of receptor and post-receptor defects in insulin action.
- To identify key contributors to hyperglycemia in NIDDM.
Main Methods:
- Review of etiological factors for insulin resistance.
- Analysis of the interplay between insulin receptor number and post-receptor signaling.
- Examination of glucose uptake and hepatic glucose oxidation pathways.
Main Results:
- Insulin resistance is induced by abnormal beta-cell secretions, circulating antagonists, or target tissue defects.
- Both decreased insulin receptors and post-receptor defects contribute to insulin resistance.
- Post-receptor defects become increasingly prominent as insulin resistance progresses.
- Impaired glucose uptake and increased hepatic glucose oxidation contribute to fasting hyperglycemia in NIDDM.
Conclusions:
- Insulin resistance is a multifactorial condition with significant implications for NIDDM pathogenesis.
- Post-receptor defects play a critical role in the progression of insulin resistance.
- Targeting these defects may offer therapeutic strategies for managing hyperglycemia.